The U.S. Food and Drug Administration has expanded the approved use of Arexvy, an RSV vaccine developed by GSK, to include adults aged 18 to 49 who are at increased risk of lower respiratory ...
Dame Emma Walmsley, CEO of GSK arrives for a business roundtable attended by President Donald Trump and Britain's Prime Minister Keir Starmer at Chequers near ...
Tim Shaw, Global Head of Supply Chain Planning CoE at GSK, will share how the company mobilized resources in just four months to reimagine integrated planning. Discover how GSK balanced rapid value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results